{
    "clinical_study": {
        "@rank": "14888", 
        "arm_group": [
            {
                "arm_group_label": "TPB", 
                "arm_group_type": "Other", 
                "description": "TREXIMET\u00ae (Attack 1), placebo (Attack 2), BCM (Attack 3)"
            }, 
            {
                "arm_group_label": "TBP", 
                "arm_group_type": "Other", 
                "description": "TREXIMET\u00ae (Attack 1), BCM (Attack 2), placebo (Attack 3)"
            }, 
            {
                "arm_group_label": "BTP", 
                "arm_group_type": "Other", 
                "description": "BCM (Attack 1), TREXIMET\u00ae (Attack 2), placebo (Attack 3)"
            }, 
            {
                "arm_group_label": "BPT", 
                "arm_group_type": "Other", 
                "description": "BCM (Attack 1), placebo (Attack 2), TREXIMET\u00ae (Attack 3)"
            }, 
            {
                "arm_group_label": "PTB", 
                "arm_group_type": "Other", 
                "description": "placebo (Attack 1), TREXIMET\u00ae (Attack 2), BCM (Attack 3)"
            }, 
            {
                "arm_group_label": "PBT", 
                "arm_group_type": "Other", 
                "description": "placebo (Attack 1), BCM (Attack 2), TREXIMET\u00ae (Attack 3)"
            }
        ], 
        "brief_summary": {
            "textblock": "Study TRX109011, A Randomized, Double-blind, Double-dummy, Placebo-controlled, Crossover\n      Study to Evaluate the Efficacy of TREXIMET\u00ae (Sumatriptan + Naproxen Sodium) versus\n      Butalbital-containing Combination Medications (BCM) for the Acute Treatment of Migraine when\n      administered during the Moderate-Severe Pain Phase of the Migraine (Study 1 of 2)"
        }, 
        "brief_title": "TREXIMET\u00ae Versus Butalbital-containing Combination Medications for the Acute Treatment of Migraine", 
        "completion_date": {
            "#text": "August 2009", 
            "@type": "Actual"
        }, 
        "condition": "Migraine Disorders", 
        "condition_browse": {
            "mesh_term": "Migraine Disorders"
        }, 
        "detailed_description": {
            "textblock": "This study is a multicenter, randomized, double-blind, double-dummy, placebo-controlled,\n      crossover, three-attack, outpatient study in which TREXIMET\u00ae will be compared to a\n      butalbital-containing combination medication (BCM; acetaminophen 325mg, caffeine 40mg, and\n      butalbital 50mg [Fioricet]) for the acute treatment of migraine headaches. Subjects will be\n      randomized to one of 6 possible treatment sequences (TPB, TBP, BTP, BPT, PTB, PBT where T =\n      TREXIMET\u00ae; P = Placebo; B = Butalbital-containing Combination Medication) .  Subjects will\n      treat each of the 3 migraine attacks when pain is moderate to severe.  The study will\n      include 4 visits:  (1) a Screening visit at study entry, (2) a Drug Screen visit, (3) a\n      Randomization visit, and (4) a Final visit.  The Final visit occurs either (A) upon\n      withdrawal or (B) after treatment of 3 migraine attacks.  The primary objective is to\n      evaluate the efficacy of TREXIMET\u00ae versus BCM for the acute treatment of moderate/severe\n      migraine."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Males and females aged 18 to 65 years.  Female subjects are eligible for\n             participation if they are either of non-childbearing potential (not capable of\n             becoming pregnant) OR of childbearing potential having a negative urine pregnancy\n             test at screening, and using contraception if sexually active.  If using oral\n             contraceptives, the subjects should be on a stable regimen of oral contraceptives\n             (>/= 2 months).\n\n        Eligible subjects must:\n\n          -  have migraine with or without aura (2004 ICHD-II criteria) and must have had at least\n             2 attacks per month meeting these criteria in the three months prior to screening.\n\n          -  have documented use of Butalbital-containing Combination Medication (MCM) to have\n             treated at least one migraine.\n\n          -  be able to understand how to complete the cognitive assessments and all other\n             questionnaires programmed in an electronic diary.\n\n          -  be willing and able to provide written informed consent.\n\n        Exclusion Criteria:\n\n        A subject is not eligible if they have:\n\n          -  >8 migraines or >/= 15 headache days per month in total, or has retinal, basilar, or\n             hemiplegic migraine, or secondary headaches.\n\n          -  taken >350mg/day of butalbital and/or other barbiturates on an equivalent dose basis,\n             on average, over the 30 days prior to screening.\n\n          -  is likely to have unrecognized cardiovascular or cerebrovascular disease (based on\n             history or risk factors).\n\n          -  blood pressure >/= 140/90mmHg in 2 out of 3 BP measurements or is taking any\n             angiotensin-converting enzyme (ACE) inhibitor or angiotensin receptor blocker.\n\n          -  history of congenital heart disease, cardiac arrhythmias requiring medication, or a\n             clinical significant electrocardiogram abnormality.\n\n          -  evidence or history of any ischemic vascular disease including:  ischemic heart\n             disease, ischemic abdominal syndromes, peripheral vascular disease or Raynaud's\n             Syndrome, or signs/symptoms consistent with these.\n\n          -  evidence or history of central nervous system pathology including stroke and/or\n             transient ischemic attacks (TIAs), epilepsy or structural brain lesions which lower\n             the convulsive threshold; or has been treated with an antiepileptic drug for seizure\n             control within 5 years prior to screening.\n\n          -  a history of impaired hepatic or renal function that contraindicates participation in\n             the study.\n\n          -  hypersensitivity, allergy, intolerance, or contraindication to the use of any\n             triptan, NSAID, aspirin, barbiturates, or acetaminophen (including all sumatriptan\n             and naproxen preparations), has porphyria or has nasal polyps and asthma.\n\n          -  is currently taking, or has taken in the previous three months, an ergot preparation\n             for migraine prophylaxis; or is taking a migraine or prophylactic medication that is\n             not stabilized (i.e. a change of dose within the last 2 months)  for either chronic\n             or intermittent migraine prophylaxis or for a co-morbid condition that is not\n             stabilized.\n\n          -  a recent history of regular use of opioids (including opioids in combination with\n             butalbital, e.g. Fioricet with codeine) or barbiturates other than butalbital.\n             Regular use is defined as an average of 4 days per month over the last 6 months.\n\n          -  taken, or plans to take, a monoamine oxidase inhibitor (MAOI), including herbal\n             preparations containing St. John's Wort (Hypericum perforatum), anytime within the 2\n             weeks prior to screening through 2 weeks post final study treatment.\n\n          -  history of any bleeding disorder or is currently taking any anti-coagulant or any\n             antiplatelet agent (except low-dose aspirin </= 325mg/day for cardioprotective\n             reasons).\n\n          -  evidence or history of any gastrointestinal surgery or GI ulceration or perforation\n             in the past six months, gastrointestinal bleeding in the past year; or evidence or\n             history of inflammatory bowel disease.\n\n          -  is pregnant, actively trying to become pregnant, breast feeding, or not willing to\n             have pregnancy test performed.\n\n          -  evidence of alcohol or substance abuse within the last year or any concurrent medical\n             or psychiatric condition which, in the investigator's judgement, will likely\n             interfere with the study conduct, subject cooperation, or evaluation and\n             interpretation of the study results, or which otherwise contraindicates participation\n             in this clinical study.\n\n          -  participated in an investigational drug trial within the previous four weeks or plans\n             to participate in another study at any time during this study."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "283", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "March 14, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01812408", 
            "org_study_id": "TRX109011"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "PBT", 
                    "PTB", 
                    "BTP", 
                    "TPB", 
                    "TBP", 
                    "BPT"
                ], 
                "description": "Sumatriptan + Naproxen Sodium (fixed dose combination tablet of sumatriptan succinate [equivalent to sumatriptan 85mg] and naproxen sodium 500mg)", 
                "intervention_name": "TREXIMET\u00ae", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "PBT", 
                    "PTB", 
                    "BTP", 
                    "TPB", 
                    "TBP", 
                    "BPT"
                ], 
                "description": "butalbital-containing combination medication (BCM; acetaminophen 325mg, caffeine 40mg, and butalbital 50mg) [currently marketed as Fioricet]", 
                "intervention_name": "Butalbital-containing Combination Medications (BCM)", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "PBT", 
                    "PTB", 
                    "BTP", 
                    "TPB", 
                    "TBP", 
                    "BPT"
                ], 
                "description": "placebo", 
                "intervention_name": "placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Naproxen", 
                "Sumatriptan"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Migraine, acute", 
            "Migraine", 
            "Butalbital-containing Combination Medication (BCM)", 
            "Naproxen sodium", 
            "Sumatriptan succinate", 
            "TREXIMET\u00ae"
        ], 
        "lastchanged_date": "March 14, 2013", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Chandler", 
                        "country": "United States", 
                        "state": "Arizona", 
                        "zip": "85224"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Litchfield Park", 
                        "country": "United States", 
                        "state": "Arizona", 
                        "zip": "85340"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tempe", 
                        "country": "United States", 
                        "state": "Arizona", 
                        "zip": "85283"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Little Rock", 
                        "country": "United States", 
                        "state": "Arkansas", 
                        "zip": "72201"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Anaheim", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "92801"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Irvine", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "92618"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Diego", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "92108"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Santa Monica", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90404"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sherman Oaks", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "91403"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Walnut Creek", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "94596"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Colorado Springs", 
                        "country": "United States", 
                        "state": "Colorado", 
                        "zip": "80909"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Clearwater", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33755"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Naples", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "34102"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Pembroke Pines", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33024"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Plantation", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33324"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "West Palm Beach", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33407-2450"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Atlanta", 
                        "country": "United States", 
                        "state": "Georgia", 
                        "zip": "30342"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rome", 
                        "country": "United States", 
                        "state": "Georgia", 
                        "zip": "30165"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Savannah", 
                        "country": "United States", 
                        "state": "Georgia", 
                        "zip": "31406"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Suwanee", 
                        "country": "United States", 
                        "state": "Georgia", 
                        "zip": "30024"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chicago", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "60614"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Gurnee", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "60031"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Indianapolis", 
                        "country": "United States", 
                        "state": "Indiana", 
                        "zip": "46256"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Paducah", 
                        "country": "United States", 
                        "state": "Kentucky", 
                        "zip": "42003"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Shreveport", 
                        "country": "United States", 
                        "state": "Louisiana", 
                        "zip": "71101"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Springfield", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "01104"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Ann Arbor", 
                        "country": "United States", 
                        "state": "Michigan", 
                        "zip": "48104"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cherry Hill", 
                        "country": "United States", 
                        "state": "New Jersey", 
                        "zip": "08002"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Ridgewood", 
                        "country": "United States", 
                        "state": "New Jersey", 
                        "zip": "7450"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Stratford", 
                        "country": "United States", 
                        "state": "New Jersey", 
                        "zip": "08084"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Albany", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "12205"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bronx", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10461"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Brooklyn", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "11235"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Mount Vernon", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10550"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10021"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Orchard Park", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "14127"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Syracuse", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "13210"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Valley Stream", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "11580"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cary", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "27518"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Charlotte", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "28204"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Greenville", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "27858"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Wilmington", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "28401"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bismarck", 
                        "country": "United States", 
                        "state": "North Dakota", 
                        "zip": "58501"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cincinnati", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "45245"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cincinnati", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "45227"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Toledo", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "43614-5809"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Oklahoma City", 
                        "country": "United States", 
                        "state": "Oklahoma", 
                        "zip": "73112"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Philadelphia", 
                        "country": "United States", 
                        "state": "Pennsylvania", 
                        "zip": "19107"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Philadelphia", 
                        "country": "United States", 
                        "state": "Pennsylvania", 
                        "zip": "19114"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Pittsburgh", 
                        "country": "United States", 
                        "state": "Pennsylvania", 
                        "zip": "15236"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Simpsonville", 
                        "country": "United States", 
                        "state": "South Carolina", 
                        "zip": "29681"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Columbia", 
                        "country": "United States", 
                        "state": "Tennessee", 
                        "zip": "38401"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cordova", 
                        "country": "United States", 
                        "state": "Tennessee", 
                        "zip": "38018"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nashville", 
                        "country": "United States", 
                        "state": "Tennessee", 
                        "zip": "37203"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dallas", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "75234"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dallas", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "75231"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Salt Lake City", 
                        "country": "United States", 
                        "state": "Utah", 
                        "zip": "84107"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "6", 
        "official_title": "A Randomized, Double-blind, Double-dummy, Placebo-controlled, Crossover Study to Evaluate the Efficacy of TREXIMET\u00ae (Sumatriptan + Naproxen Sodium) vs. Butalbital-containing Combination Medications for the Acute Treatment of Migraine When Administered During the Moderate-Severe Migraine Pain, 1 of 2", 
        "overall_official": {
            "affiliation": "GlaxoSmithKline", 
            "last_name": "GSK Clinical Trials", 
            "role": "Study Director"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "August 2009", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Sustained pain-free (SPF) response from 2-24 hours in subjects using TREXIMET\u00ae versus those using BCM.", 
            "time_frame": "2-24 hours"
        }, 
        "reference": [
            {
                "PMID": "11903523", 
                "citation": "Silberstein SD, McCrory DC. Butalbital in the treatment of headache: history, pharmacology, and efficacy. Headache. 2001 Nov-Dec;41(10):953-67. Review."
            }, 
            {
                "PMID": "15154858", 
                "citation": "Bigal ME, Rapoport AM, Sheftell FD, Tepper SJ, Lipton RB. Transformed migraine and medication overuse in a tertiary headache centre--clinical characteristics and treatment outcomes. Cephalalgia. 2004 Jun;24(6):483-90."
            }, 
            {
                "PMID": "12173787", 
                "citation": "Wenzel RG, Sarvis CA. Do butalbital-containing products have a role in the management of migraine? Pharmacotherapy. 2002 Aug;22(8):1029-35. Review."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01812408"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Cognitive efficiency as measured by the Mental Efficiency Workload Test (MEWT)", 
                "time_frame": "0-48 hours after treatment"
            }, 
            {
                "measure": "Pain-free (PF) at 2 hours post-treatment", 
                "time_frame": "2 hours after treatment"
            }, 
            {
                "measure": "Rescue medication usage after treatment of migraine", 
                "time_frame": "0-48 hours after treatment"
            }, 
            {
                "measure": "Pain and traditional and non-traditional associated migraine symptoms including nausea, vomiting, photophobia, phonophobia, sinus pain, neck pain, irritability and tiredness", 
                "time_frame": "0-48 hours after treatment"
            }
        ], 
        "source": "GlaxoSmithKline", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "GlaxoSmithKline", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "February 2008", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2013"
    }
}